NPM1 has also been found to be associated with the progression of various human solid tumors, such as hepatocellular carcinoma, colon cancer, and prostate cancer, among other oncological diseases 29-31, and high levels of NPM1 can be observed in cancer tissue compared to paraneoplastic tissue. Here, NPM1 is linked to prostate carcinoma.